Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Reumatismo ; 76(1)2024 Mar 22.
Artículo en Inglés | MEDLINE | ID: mdl-38523582

RESUMEN

OBJECTIVE: To report cross-sectionally serum levels of 25-hydroxyvitamin D [25(OH)D] in women living in Italy within 12 months from breast cancer (BC) diagnosis. METHODS: Baseline data were obtained from 394 women diagnosed with primary BC, enrolled from 2016 to 2019 in a lifestyle trial conducted in Italy. Subjects' characteristics were compared between two 25(OH)D concentrations (hypovitaminosis D<20 and ≥20 ng/mL) with the Chi-squared test or Fisher's exact test for small-expected counts. Using multiple logistic regression-adjusted models, we estimated odds ratios (ORs) of hypovitaminosis D with 95% confidence intervals (CIs) in the total sample and in the unsupplemented subgroup. RESULTS: Hypovitaminosis D was found in 39% of all subjects, 60% in unsupplemented subjects, and 10% in supplemented subjects. Increasing ORs of hypovitaminosis D were found with increasing body mass index, 25-30, >30, and ≥35 versus <25 kg/m2 (ORs: 2.50, 4.64, and 5.81, respectively, in the total cohort and ORs: 2.68, 5.38, and 7.08 in the unsupplemented); living in the most southern Italian region (OR 2.50, 95%CI 1.22-5.13); and with hypertriglyceridemia (OR 2.46; 95%CI 1.16-5.22), chemotherapy history (OR 1.86, 95%CI 1.03-3.38), and inversely with anti-estrogenic therapy (OR 0.43, 95%CI 0.24-0.75) in the total sample. CONCLUSIONS: Hypovitaminosis D in women recently diagnosed with BC and participating in a lifestyle trial in Italy was widespread and highest with obesity, hypertriglyceridemia, and chemotherapy use. Considering that hypovitaminosis D is a risk factor for lower efficacy of bone density treatments and possibly BC mortality, our results suggest the need to promptly address and treat vitamin D deficiency.


Asunto(s)
Neoplasias de la Mama , Hipertrigliceridemia , Deficiencia de Vitamina D , Vitamina D , Femenino , Humanos , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/complicaciones , Hipertrigliceridemia/complicaciones , Italia/epidemiología , Estilo de Vida , Factores de Riesgo , Vitamina D/análogos & derivados , Deficiencia de Vitamina D/epidemiología
2.
Proc Natl Acad Sci U S A ; 117(26): 14851-14856, 2020 06 30.
Artículo en Inglés | MEDLINE | ID: mdl-32541036

RESUMEN

The Mid-Upper Paleolithic (Gravettian) karstic Grotte de Cussac (France) contains two areas of human remains in the context of abundant (and spectacular) parietal engravings. The first area (loci 1 and 2) includes the skeleton of a young adult male in a bear nest, rearranged by postdecomposition inundation, and the variably fragmentary remains of at least two individuals distributed across two bear nests, sorted anatomically and with most of the elements constrained to one side of one nest. The second area (locus 3) retains remains of two adults and an adolescent, in upper hollows and variably distributed down the slope, largely segregated into upper versus lower body groups. The only decoration associated with the human remains is red pigment on some of the bones or underlying sediment. The human remains indicate variable nonnatural deposition and manipulation of human bodies, body portions, and skeletal elements of at least six individuals. Moreover, Cussac is unusual in the association of these remains with exceptional parietal art. The complex Cussac mortuary pattern joins growing evidence from other Gravettian sites of variable treatment of individuals after death, within and across sites, in terms of formal deposition of the body versus postmortem manipulation versus surface abandonment. It provides a window onto the social diversity and the complex interactions of the living and the dead among these successful Late Pleistocene foragers.


Asunto(s)
Entierro/historia , Adulto , Animales , Arqueología , Huesos/anatomía & histología , Cuevas , Francia , Historia Antigua , Humanos , Masculino , Adulto Joven
3.
Eur Rev Med Pharmacol Sci ; 21(18): 4243-4251, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29028072

RESUMEN

OBJECTIVE: Vitamin D is a fat-soluble secosteroid hormone that regulates calcium, magnesium, and phosphate homeostasis and plays a pivotal role as antiproliferative and immunomodulatory mediator. Considering the different sources of synthesis and dietary intake as well as the pleiotropic actions in extremely diverse (micro)environments of the body, the supplementation of this Vitamin should be carefully evaluated taking into account the several pathways that it regulates. In the current brief review, we aimed to summarize the available evidence about the topic, in order to suggest the best evidence-based supplementation strategy for human reproduction, avoiding the unuseful (and sometimes hazardous) empiric supplementation. MATERIALS AND METHODS: Narrative overview, synthesizing the findings of literature retrieved from searches of computerized databases. RESULTS: Accumulating evidence from in vitro fertilization (IVF) trials suggests that fertilization rate decreases significantly with increasing levels of 25OH-D in follicular fluid; in addition, Vitamin D levels in the follicular fluid are negatively correlated to the quality of embryos and the higher values of Vitamin D are associated with lower possibility to achieve pregnancy. Both low and high Vitamin D serum concentrations decrease not only spermatozoa count, but their progressive motility as well as increase morphological abnormalities. Finally, studies in animal models found that severe hypervitaminosis D can reduce the total skeletal calcium store in embryos and may compromise the postnatal survival. CONCLUSIONS: Based on the retrieved data, we solicit to be extremely selective in deciding for Vitamin D supplementation, since its excess may play a detrimental role in fertility.


Asunto(s)
Fertilidad , Vitamina D/metabolismo , Vitaminas/metabolismo , Animales , Calcio/metabolismo , Suplementos Dietéticos , Femenino , Fertilización In Vitro , Líquido Folicular/metabolismo , Humanos , Embarazo , Vitamina D/sangre , Deficiencia de Vitamina D/complicaciones
4.
Int J Paleopathol ; 17: 67-74, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28521913

RESUMEN

Clear skeletal evidence of prehistoric tuberculosis (TB) is rare, especially in children. We describe and differentially diagnose the pathological changes displayed by a five-year-old child, Pollera 21 (PO21) dated to the Middle Neolithic of Liguria (Italy), or 5740±30 BP (Beta-409341; 6635-6453cal BP, 2σ, OxCal 4.2). PO21 shows a number of osteoarticular lesions, mainly of a lytic nature with very little bone proliferation: the vertebral column, the shoulder and pelvic girdles, and the ribcage are involved. Given the nature and pattern of the lesions, we propose a diagnosis of multifocal (or multiple) bone TB. Attempts to detect TB aDNA through molecular analysis gave negative results, but this alone is not sufficient to prove that PO21 was not infected with TB. The lesions observed in PO21 share similarities with other published evidence, such as spinal and joint involvement, and disseminated cyst-like lesions. Conversely, PO21 does not show diffuse bone deposition, such as hypertrophic osteoarthropathy (HOA) or endocranial modifications such as serpens endocrania symmetrica (SES). PO21 adds to our knowledge of patterns of TB manifestation in archaeological skeletal remains, which is especially important considering the variability in types and patterns of osteoarticular lesions seen today in people with TB.


Asunto(s)
Tuberculosis Osteoarticular/historia , Tuberculosis Osteoarticular/patología , Preescolar , Historia Antigua , Humanos , Italia , Paleopatología
5.
Clin Exp Obstet Gynecol ; 42(6): 743-5, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26753476

RESUMEN

PURPOSE OF INVESTIGATION: To evaluate the effect of soy isoflavones and inulin (SII) on hot flushes (HF) and quality of life in a clinical setting, the authors conducted an observational study. MATERIALS AND METHODS: The authors performed an observational, prospective, multicentric study on women in peri-/post-menopause treated or untreated with a product present on the Italian market, consisting in a mixture of calcium (500 mg), vitamin D3 (300 IU), inulin (3 g) and soy isoflavones (40 mg). RESULTS: A total of 135 patients, 75 (55.6%) in the SII group and 60 (44.4%) in the untreated group entered the study. After three months, the mean number of HF declined of 2.8 (SD 3.7) in the SII group and 0.0 in the untreated one. The corresponding values after six months were -3.7 (SD 2.7) in the SII group and -0.9 (SD 5.3) in the control group (p = 0.02). CONCLUSION: This observational trial suggests a possible beneficial effect of a dietary soy supplement containing 40 mg of isoflavone/day plus inulin in the management of menopausal symptoms such as hot flashes.


Asunto(s)
Sofocos/tratamiento farmacológico , Inulina/administración & dosificación , Isoflavonas/administración & dosificación , Calidad de Vida , Calcio/administración & dosificación , Colecalciferol/administración & dosificación , Suplementos Dietéticos , Quimioterapia Combinada , Femenino , Sofocos/fisiopatología , Humanos , Menopausia , Persona de Mediana Edad , Estudios Prospectivos , Glycine max , Resultado del Tratamiento
6.
Transplant Proc ; 46(7): 2238-40, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25242760

RESUMEN

BACKGROUND: Persistent or "de novo" anemia (plasma hemoglobin<11 g/dL) may complicate the graft outcome in a significant number of renal transplant recipients. We describe a single-center experience with epoetin-zeta (EPO-Z), the biosimilar form for epoetin-alfa. METHODS: Twenty patients were included in the study, 10 in treatment with different erythropoiesis-stimulating agents (ESA) and shifted to EPO-Z (shift group) and 10 who started EPO-Z treatment for anemia (naive group). All the patients had stable renal function and normal values of main inflammation markers and were prospectively followed up for 12 months. Iron supplements were administered during the study, as needed. RESULTS: In the shift group, mean plasma hemoglobin levels>11 g/dL were maintained for the entire 1-year follow-up period, with average EPO-Z doses 3.4% higher than the corresponding doses of previous ESA; in the naive group, the target value was reached between the first and third months and remained stable throughout the study. Mean corpuscular volume did not vary in either group. No change was observed in glomerular filtration rate, nor in proteinuria or in main laboratory data. No drug-related side effect was reported. CONCLUSIONS: EPO-Z may be considered a valid alternative to different ESAs in renal transplant recipients, with an interesting pharmaco-economic profile, considering its lower cost.


Asunto(s)
Anemia/tratamiento farmacológico , Eritropoyetina/uso terapéutico , Hematínicos/uso terapéutico , Trasplante de Riñón , Receptores de Trasplantes , Epoetina alfa , Eritropoyetina/economía , Femenino , Estudios de Seguimiento , Hematínicos/economía , Hemoglobinas/análisis , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Proteínas Recombinantes/economía , Proteínas Recombinantes/uso terapéutico
7.
Holist Nurs Pract ; 13(4): 51-60, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10661118

RESUMEN

Across the United States, advance practice nurses (APNs) are increasingly encountering recently immigrated Latin American populations. This article provides an overview of the situation of Latin Americans in the United States and discusses aspects of Latin American culture such as, respeto (respect), confianza (confidence), the importance of family, and the value of a personal connection. Strategies that will assist practitioners to incorporate culturally holistic principles in the promotion of breastfeeding among Latin American women who are new arrivals in the United States are described. If practitioners are to respond to the increasing numbers of Latin American women who need health care services, and also provide thorough, holistic health care then health care activities must be integrated with cultural competence.


Asunto(s)
Lactancia Materna/etnología , Lactancia Materna/psicología , Promoción de la Salud/métodos , Hispánicos o Latinos/psicología , Enfermería Holística/métodos , Enfermería Transcultural/métodos , Migrantes , Adulto , Actitud Frente a la Salud/etnología , Femenino , Conocimientos, Actitudes y Práctica en Salud , Hispánicos o Latinos/educación , Humanos , Enfermeras Clínicas , Enfermeras Practicantes , Embarazo , Estados Unidos
8.
J Air Waste Manag Assoc ; 49(2): 225-228, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28085657

RESUMEN

A tunable electron beam generated plasma system has been developed for selective cold plasma treatment of dilute concentrations (1-3,000 ppm range) of hazardous compounds in gaseous waste treatment. This system, referred to as the Tunable Hybrid Plasma (THP), has shown a high degree of efficiency and effectiveness in both laboratory and field tests. Decomposition energy requirements are in the 100 eV per molecule range for treatment of carbon tetrachloride and 10 eV for treatment of trichloroethylene. A cost comparison has been made between the Tunable Hybrid Plasma (THP) technology and three conventional technologies used for emission control of volatile organic compounds (VOCs): granular activated carbon, thermal incineration, and catalytic oxidation. In addition to its environmentally attractive features, THP technology has the potential to be lower cost than other technologies over a range of concentrations and flow rates. Cost projections for the THP system for decomposition of trichloroet-hylene are around 50 cents/lb for initial concentrations in the few hundred ppm range and flow rates of 5,000 cfm or greater and around $1/lb for 1,000 cfm flow rates. Cost projections for carbon tetrachloride and trichloroethane decomposition using the THP technology are several dollars per pound. The costs for THP treatment are generally significantly lower than costs for use of granular activated carbon and are also quite competitive with costs for thermal incineration and catalytic oxidation.

9.
Arch Ophthalmol ; 112(2): 222-7, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8311777

RESUMEN

OBJECTIVES: The relationships between fasting plasma levels of retinol, ascorbic acid, alpha-tochopherol, and beta-carotene and age-related macular degeneration (AMD) were studied in a population enrolled in the Baltimore Longitudinal Study of Aging (BLSA), in which most of the data were collected 2 or more years before assessment of macular status. DESIGN: A total of 976 participants in the study were scheduled for a biennial examination from January 1988 through January 1, 1990, which included taking lens and macular photographs. A total of 827 (85%) of the participants had fundus photographs taken, and most plasma data were available for 82% of those subjects with fundus photographs. Age-related macular degeneration was defined as neovascular changes, geographic and nongeographic atrophy, large or confluent drusen, or hyperpigmentation. A total of 226 cases of AMD were available for analysis. RESULTS: Logistic regression analyses suggested that alpha-tocopherol was associated with a protective effect for AMD, adjusted for age, sex, and nuclear opacity. An antioxidant index, including ascorbic acid, alpha-tocopherol, and beta-carotene, was also protective for AMD. Our conclusions must be tempered with the knowledge that the population under study was basically well nourished, and few individuals had any clinically deficient status. The study cannot exclude the possibility that quite low levels of micronutrients, lower than those observed in this study, might be risk factors for AMD. CONCLUSIONS: The data suggest a protective effect for AMD of high plasma values of alpha-tocopherol. An antioxidant index, composed of plasma ascorbic acid, alpha-tocopherol, and beta-carotene, was also protective. The use of vitamin supplements to prevent AMD is not supported by these data, which showed no protective effect of vitamin use.


Asunto(s)
Antioxidantes/administración & dosificación , Degeneración Macular/prevención & control , Adulto , Anciano , Anciano de 80 o más Años , Catarata/patología , Femenino , Humanos , Estudios Longitudinales , Degeneración Macular/sangre , Masculino , Persona de Mediana Edad , Medicamentos sin Prescripción/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA